NCT03012698

Pilot Study for Testing Safety of Repetitive Magnetic Stimulation for Treatment of Dry Eye

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 29 (actual)
• Sponsor: Epitech Mag Ltd. · Industry
• Sex: All
• Age: 18 Years – 80 Years
• Healthy volunteers: Not accepted

Summary

The study aims to test the safety of Repetitive Magnetic Stimulation (RMS) treatment for dry eye disease. Patients are asked to undergo a one-time treatment with Epitech Ocular Magnetic Stimulation Device on one eye in the first stage and both eyes sequentially in the second stage of the study. Changes are monitored for over a study period of 3 months.

Conditions

• Dry Eye
• Sjogren's Syndrome
• Aqueous Tear Deficiency
• Meibomian Gland Dysfunction
• Dry Eye Syndromes

Interventions

Type	Name	Description
DEVICE	Ocular Repetitive Magnetic Stimulation (RMS) treatment	First stage: Patients will be asked to undergo a one-time treatment with Epitech Corneal Magnetic Stimulation Device on one eye. The worst eye will be treated; if both eyes are equal, the right eye will be treated. Second stage: will be treated on both eyes, applying treatment to both eyes sequentially during the same visit.

Timeline

• Start date: 2017-11-01
• Primary completion: 2019-06-17
• Completion: 2019-06-17
• First posted: 2017-01-06
• Last updated: 2019-11-25

Locations

3 sites across 1 country: Israel